PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Newly Unified Unilever Sets Out Growth Ambitions

Thu, 04th Feb 2021 08:21

(Alliance News) - Consumer products giant Unilever said Thursday it delivered a strong set of annual results under the most difficult of circumstances brought about by the coronavirus pandemic, while also setting out a plan for growth.

Unilever shares were down 3.9% at 4,168.00 pence early Thursday.

For 2020, Unilever posted revenue of EUR50.72 billion, down 2.4% from USD51.98 billion in 2019, just missing forecasts of EUR50.81 billion.

Underlying operating profit was EUR9.34 billion in 2020, down from EUR9.94 billion in 2019. The Anglo-Dutch company posted underlying sales growth of 1.9%.

Unilever declared a quarterly dividend of EUR0.4268, which it noted was up 4%. This is about 37.7 pence.

Looking ahead, Unilever said it would aim for underlying sales growth ahead of its markets, delivering growth in the range of 3% to 5%, as well as profit growth ahead of sales growth.

CEO Alan Jope said: "We progressed our strategic agenda, building on our existing sustainability commitments with ambitious new targets and actions, most recently with our plans to help build a more equitable and inclusive society. We completed the unification of our legal structure under a single parent company and we continue to work on separating out the tea business as we evolve our portfolio.

"Today we are setting out our plans to drive long-term growth through the strategic choices we are making and outlining our multi-year financial framework. While volatility and unpredictability will continue throughout 2021, we begin the year in good shape and are confident in our ability to adapt to a rapidly changing environment."

Other elements of Unilever's plan is to develop its product portfolio into "high growth spaces". It also will push harder to grow in the US, India and China, from which 35% of it turnover already comes.

Unilever said it make restructuring investment of EUR1 billion in each of 2021 and 2022, with this reducing thereafter. It is aiming for EUR2 billion per annum of savings from its established 'Fuel for Growth' effort.

It is targeting return on invested capital in the mid-to-high teens and a ratio of net debt to underlying earnings before interest, tax, depreciation and amortisation of about 2 times.

Back in November, Unilever completed the unification of its group legal structure into a single parent company headquartered in the UK but still listed in Amsterdam, New York and London.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.4% at 6,530.66

----------

Hang Seng: down 0.7% at 29,101.74

Nikkei 225: closed down 1.1% at 28,341.95

DJIA: closed up 36.12 points, or 0.1%, at 30,723.60

S&P 500: closed up 3.86 points, or 0.1%, at 3,830.17

----------

GBP: down at USD1.3598 (USD1.3651)

EUR: down at USD1.2003 (USD1.2022)

Gold: down at USD1,825.03 per ounce (USD1,835.90)

Oil (Brent): up at USD58.94 a barrel (USD58.64)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's Key Economic Events still to come

0930 GMT UK CIPS-Markit construction purchasing managers' index

1100 GMT Ireland industrial production and turnover

1200 GMT UK Bank of England interest rate decision

1200 GMT UK BoE quarterly monetary policy report

1300 GMT UK BoE Governor Andrew Bailey press conference

1100 CET EU retail sales

0730 EST US challenger job-cut report

0830 EST US preliminary productivity and costs

0830 EST US initial jobless claims

1030 EST US EIA weekly natural gas storage report

----------

Former European Central Bank chief Mario Draghi urged Italy's splintered parties Wednesday to get behind him as he tries to form a new government and lift his country out of the devastation of the coronavirus pandemic. After receiving a mandate from President Sergio Mattarella to open talks on a national unity government, Draghi stressed the urgency of resolving the political chaos at such a "difficult moment". There has been no fully functioning government in Rome for weeks, as Giuseppe Conte's ruling coalition slowly collapsed in a row over the handling of Covid-19 and the resulting deep recession.

----------

BROKER RATING CHANGES

----------

DEUTSCHE BANK CUTS GLAXOSMITHKLINE TO 'SELL' (HOLD) - PRICE TARGET 1150 (1400) PENCE

----------

ODDO BHF RAISES RELX TO 'OUTPERFORM' (NEUTRAL)

----------

JEFFERIES RAISES PRUDENTIAL TO 'BUY' (HOLD) - PRICE TARGET 1450 (1455) PENCE

----------

GOLDMAN SACHS RAISES ASOS PRICE TARGET TO 6,500 (5,800) PENCE - 'BUY'

----------

COMPANIES - FTSE 100

----------

Shell swung to an annual loss in a year when the Covid-19 pandemic hit energy consumption. Brent oil was quoted at USD58.90 a barrel Thursday morning, up from USD58.64 at the London equities close Wednesday. The North Sea benchmark was trading around USD68 a barrel at the start of 2020, but collapsed to a low of USD15.97 in April due to the global economic impact of the virus and a Russia-Saudi Arabia output war later resolved. For 2020, Shell swung to a loss attributable to shareholders of USD21.68 billion from a profit of USD15.84 billion in 2019. Adjusted earnings were USD4.84 billion, down 71% from USD16.46 billion - missing consensus forecasts for USD5.05 billion. For the fourth quarter alone, Shell swung to a loss attributable to shareholders of USD4.01 billion from a USD965 million profit in 2019. Free cash flow for 2020 was USD17.63 billion, down 12% from USD20.1 billion in 2019. Net debt increased by USD1.9 billion to USD75.4 billion in the fourth quarter, hurt by lower free cash flow, including a small working capital outflow. Shell slashed its fourth quarter payout 65% to USD0.1665 from USD0.4700. Its annual dividend was down 65% to USD0.6530. Shell expects its first quarter 2021 dividend to be USD0.1735. Looking ahead to the first quarter, Shell said production was expected in a range between 900,000 to 950,000 barrels of oil per day. "2020 was an extraordinary year. We have taken tough but decisive actions and demonstrated highly resilient operational delivery while caring for our people, customers and communities. We are coming out of 2020 with a stronger balance sheet, ready to accelerate our strategy and make the future of energy. We are committed to our progressive dividend policy and expect to grow our US dollar dividend per share by around 4% as of the first quarter 2021," said Chief Executive Officer Ben van Beurden.

----------

COMPANIES - GLOBAL

----------

SoftBank Group said its performance improved in the first nine months of its current financial year. The Tokyo-based company which owns stakes in many technology, energy, and financial companies said revenue for the nine months to the end of 2020 rose by 5.2% when compared to the prior year to JPY3.807 trillion. Pretax profit, meanwhile, increased by 2.3% to JPY746.20 billion. Operating income was 5.8% higher than a year earlier, at JPY841.58 billion. Net income rose by 3.5% to JPY485.50 billion.

----------

Basel, Switzerland-based pharmaceutical group Roche Holdings reported a stronger performance for 2020, with profit rising despite a drop in sales. For the year, Roche posted net income of CHF15.07 billion, around USD20.07 billion, which reflects a 7% rise from CHF14.11 billion the year before, due to a drop in goodwill write-offs. Diluted earnings per share however was down 5% year-on-year at CHF19.16 from CHF20.16. Group sales however, declined by 5% to CHF58.32 billion from CHF61.47 billion in 2019, which Roche attributed to the continued appreciation of the Swiss franc against most currencies. At constant exchange rates however, sales rose by 1%.

----------

Thursday's Shareholder Meetings

Compass Group PLC - AGM

DCC PLC - GM re replacement of CREST system

Hostelworld Group PLC - GM re changes to borrowing limit

Microsaic Systems PLC - GM re share placing

Octopus Renewables Infrastructure Trust PLC - GM re investment policy changes

Sage Group PLC - AGM

Stock Spirits Group PLC - AGM

Ten Lifestyle Group PLC - AGM

Yew Grove REIT PLC - EGM re migration from CREST

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.